Xenon Pharmaceuticals (FRA:XP0) Price-to-Operating-Cash-Flow : (As of May. 16, 2024)

View and export this data going back to 2014. Start your Free Trial

What is Xenon Pharmaceuticals Price-to-Operating-Cash-Flow?

As of today (2024-05-16), Xenon Pharmaceuticals's share price is €37.40. Xenon Pharmaceuticals's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was €-2.04. Hence, Xenon Pharmaceuticals's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Xenon Pharmaceuticals's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 13 years, Xenon Pharmaceuticals's highest Price-to-Operating-Cash-Flow Ratio was 112.91. The lowest was 83.77. And the median was 90.23.

FRA:XP0's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 26.35
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Xenon Pharmaceuticals's Cash Flow from Operations per share for the three months ended in Mar. 2024 was €-0.51. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was €-2.04.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -16.00% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -24.50% per year.

During the past 13 years, Xenon Pharmaceuticals's highest 3-Year average Operating Cash Flow per Share Growth Rate was 47.60% per year. The lowest was -107.50% per year. And the median was -12.10% per year.

Xenon Pharmaceuticals Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Xenon Pharmaceuticals's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xenon Pharmaceuticals Price-to-Operating-Cash-Flow Chart

Xenon Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

Xenon Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Xenon Pharmaceuticals's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Xenon Pharmaceuticals's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Xenon Pharmaceuticals's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Xenon Pharmaceuticals's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Xenon Pharmaceuticals's Price-to-Operating-Cash-Flow falls into.

Xenon Pharmaceuticals Price-to-Operating-Cash-Flow Calculation

Xenon Pharmaceuticals's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	37.40	/	-2.043
	=

Xenon Pharmaceuticals's Share Price of today is €37.40.
Xenon Pharmaceuticals's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-2.04.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Xenon Pharmaceuticals Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Xenon Pharmaceuticals's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Xenon Pharmaceuticals (FRA:XP0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xenon Pharmaceuticals Inc (FRA:XP0) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

XENE:USA

Address

200-3650 Gilmore Way, Burnaby, BC, CAN, V5G 4W8

Website

https://www.xenon-pharma.com

Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901, and XEN496 for Epilepsy, and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out throughout Canada.

Xenon Pharmaceuticals (FRA:XP0) Headlines

No Headlines